The expression of PSMA in both healthy kidneys and in the tumor-associated neovasculature of primary and metastatic tissues could make the use of PSMA-targeted imaging very useful in the staging and restaging of RCC. This evidence concerns the gene FOLH1 and renal cell carcinoma.